Microbot Medical (MBOT) Short-term Investments (2010 - 2026)

Microbot Medical (MBOT) has 13 years of Short-term Investments data on file, last reported at $68.8 million in Q1 2026.

• Quarterly Short-term Investments rose 153.35% year-over-year to $68.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.8 million (up 153.35% YoY) and the FY2025 annual result came in at $74.7 million, up 3069.78% from the prior year.
• Short-term Investments fell to $68.8 million in Q1 2026, from $74.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $74.7 million in Q4 2025 to a low of $2.0 million in Q1 2022.
• A 5-year average of $18.7 million and a median of $4.2 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments slumped 60.03% — and 2025, when it soared 3069.78%.
• Tracing MBOT's Short-term Investments over 5 years: stood at $5.8 million in 2022, then sank by 32.0% to $3.9 million in 2023, then plunged by 39.85% to $2.4 million in 2024, then soared by 3069.78% to $74.7 million in 2025, then retreated by 7.82% to $68.8 million in 2026.
• The last three Short-term Investments figures came in at $68.8 million (Q1 2026), $74.7 million (Q4 2025), and $73.5 million (Q3 2025), per Business Quant data.